• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Stryker lowers guidance on first-quarter sales slip

Stryker lowers guidance on first-quarter sales slip

April 22, 2009 By MassDevice staff

It seems the hospital bed business ain’t what she used to be, at least for Stryker Corp.

Slumping sales for its medical/surgical equipment division during the quarter ended March 31 meant the Kalamazoo-based medical products giant needed its orthopedic division to provide some padding.

But the princess felt the pea as the division, which includes Hopkinton’s Stryker Biotech, failed to deliver enough of a cushion. Stryker lowered its 2009 guidance, citing weak med/surg sales.

In January, the company said it expected net earnings per share to be in the range of $3.12 to $3.22, with a 6 percent to 9 percent jump in sales.

Today the company said a more realistic forecast puts those numbers in the $2.90 to $3.10 range, with only a 2 percent to 5 percent increase in sales.

The med/surg division, which derives more than a third of its income from “patient handling and emergency equipment”—stretchers and hospital beds—posted $628 million in sales for the three months ended March 31, down 5 percent compared with $663 million during the same period last year.

Most of that slide was attributable to slow sales for Stryker’s patient handling line; the company’s line of hospital beds is one area where it usually makes some hay, but the line’s sales were down 27 percent in 2009.

In 2008, the division led its division in terms of growth, stretching 18 percent in 2008 on the back of hospital bed sales to maternity wards all over the U.S, Canada, and Latin America, according to a filing with the federal Securities and Exchange Commission.

Sales in Stryker’s orthopedic division were flat at $973 million compared with $971 million during the same period last year.

Predictably, the soft sales dragged down the bottom line. Stryker recorded $289 million in net income for the quarter, down 3.2 percent from the same period in 2008.

Officials blamed the “unprecedented global economic slowdown” for the downshift.

Stryker Biotech has been in the news lately after three of its sales representatives copped guilty pleas to a federal investigation of off-label promotion.

Filed Under: Uncategorized

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy